ILD Biomarker registry, Canada
Objective: Numerous conditions make up the group of disorders called interstitial lung disease (ILD). Most cause progressive scarring of lung tissue that eventually affects your ability to breathe and get enough oxygen into your bloodstream, but beyond this, the disorders vary greatly. Understanding the similarities and differences of these diseases will aid in identifying biomarkers (a specific physical trait used to measure or indicate the effects or progress of a disease or condition) that correlate with disease severity or progression. This biobank will aid access to patient samples in order to conduct research and improve our understanding of ILD.
|Registered Biobank Name||ILD Biomarker registry|
|Biobank Leader||Chris Ryerson|
|Email for biobank firstname.lastname@example.org|
|Principal Investigator||Chris Ryerson|